Suppr超能文献

肾缺血作为氯化汞肾毒性病因的证据。

Evidence for renal ischaemia as a cause of mercuric chloride nephrotoxicity.

作者信息

Girardi G, Elías M M

机构信息

Facultad de Ciencias Bioquimicas y Farmacéuticas, Rosario, República Argentina.

出版信息

Arch Toxicol. 1995;69(9):603-7. doi: 10.1007/s002040050220.

Abstract

The present study was undertaken to investigate if the source of oxidative stress and the renal injury produced by mercuric chloride could be renal ischaemia. Verapamil Vp was used because it was described that calcium channel blockers protect cells from nephrotoxicants and from ischaemia. Vp (75 micrograms/kg, i.v.; 30 min before HgCl2 injection) prevented mercuric chloride renal injury observed 1 h post-HgCl2 injection as measured by clearance techniques. Vp also prevented the diminution of non-protein-sulfhydryls (NPSH) and the increased lipid peroxidation (LPO) induced by HgCl2 in renal tissue. Hg2+ toxicokinetic alterations were not observed in Vp plus HgCl2 treated rats, nor was Vp ability found as a free radical scavenger in renal tissue homogenates. The results described in this study give some evidence for the role of renal ischaemia in the production of oxidative stress, generating LPO and functional and morphological renal injury described in mercuric chloride treated rats.

摘要

本研究旨在探究氯化汞产生的氧化应激源及肾损伤是否可能是肾缺血。使用维拉帕米(Vp)是因为有描述称钙通道阻滞剂可保护细胞免受肾毒物和缺血的影响。Vp(75微克/千克,静脉注射;在注射HgCl2前30分钟)可预防注射HgCl2 1小时后通过清除技术测量的氯化汞肾损伤。Vp还可预防肾组织中由HgCl2诱导的非蛋白巯基(NPSH)减少和脂质过氧化(LPO)增加。在Vp加HgCl2处理的大鼠中未观察到Hg2+毒代动力学改变,在肾组织匀浆中也未发现Vp具有自由基清除剂的能力。本研究中描述的结果为肾缺血在氧化应激产生中的作用提供了一些证据,氧化应激会产生LPO以及在氯化汞处理的大鼠中出现的功能性和形态学肾损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验